International Journal of Pharmacognosy and Pharmaceutical Sciences

Vol. 3, Issue 1, Part A (2021)

Menstrual blood-use in regenerative medicine

Author(s):

M Apoorva, T Anjali, S Suvedha, S Karunavardhan, S Saran Kumar and D Hepcy Kalarani

Abstract:

Women producenatural life; but now they will add medically to save lives through the Endometrial Regenerative Cells (ERC) or stem cells reaped from unwanted menstrual fluid, recognized to be the most revoltingstage of woman's life. Menstrual blood, as researchers said that, is found to be the most potent source of stem cells so far.Discovering curative power of stem cells has been a revolutionary breakthrough in the field of surgery and medicine till date, which has actually given many the precious gift of life. The uterine endometrial lining, aannoying source of stem cells, is shed in menstrual process every month. In the rebuilding process that ranges over seven days, billions of cells develop creating almost 5 millimeter-thick lining. These self-renewing cells, also called Endometrial Regenerative Cells, can be developed into other tissues under controlled laboratory conditions and have multipotent markers analogous to stem cells from other sources. The requirement for regenerative therapies incorporating cells that have the ability to engraft and differentiate is vast. Mesenchymal stem cells resulting from bone marrow are presently in clinical trials after demonstrating safety and efficacy in animal models for allogeneic use due to their immunosuppressive proper-ties. Due to their simplicity of collection and isolation, MenSCs would be a great impendingbasis of multipotent cells if they also showed these properties.

Pages: 44-48  |  15 Views  7 Downloads

How to cite this article:
M Apoorva, T Anjali, S Suvedha, S Karunavardhan, S Saran Kumar and D Hepcy Kalarani. Menstrual blood-use in regenerative medicine. Int. J. Pharmacognosy Pharm. Sci. 2021;3(1):44-48. DOI: 10.33545/27067009.2021.v3.i1a.87
Call for book chapter